Thank you for your contribution to NAN’s improving Impact Factor, now 4.837*
View in a web browser | View in a mobile device

Wiley Logo  
Neuropathology and Applied Neurobiology
2012 Impact Factor for NAN has increased to 4.837*
Neuropathology and Applied Neurobiology

View Sample Issue

Sign up for e-alerts
  We thought you would like to know that your article was among the top cited articles for Neuropathology and Applied Neurobiology, clearly contributing to the journal’s increased Impact Factor. Thank you for your support. We look forward to receiving your future submissions and to an ever-increasing Impact Factor.

Top Cited papers Cited in 2012
Source items published in 2011

Leucocyte–endothelial cell crosstalk at the blood–brain barrier: A prerequisite for successful immune cell entry to the brain
J. Greenwood, S. J. Heasman, J. I. Alvarez, A. Prat, R. Lyck, B. Engelhardt
Volume 37, Issue 1

Cerebral microvascular pathology in ageing and neurodegeneration
W. R. Brown, C. R. Thore
Volume 37, Issue 1

Molecular pathogenesis of blood–brain barrier breakdown in acute brain injury
S. Nag, A. Kapadia, D. J. Stewart
Volume 37, Issue 1

Sporadic cerebral amyloid angiopathy
J. Attems, K. Jellinger, D. R. Thal, W. Van Nostrand
Volume 37, Issue 1

An update on inflammatory and autoimmune myopathies
M. C. Dalakas
Volume 37, Issue 3

The three new pathways leading to Alzheimer's disease
K. Morgan
Volume 37, Issue 4

The neuropathology of drug abuse
A. Büttner
Volume 37, Issue 2

Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
F. Orzan, S. Pellegatta, P. L. Poliani, F. Pisati, V. Caldera, F. Menghi, D. Kapetis,
C. Marras, D. Schiffer, G. Finocchiaro

Volume 37, Issue 4

The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis
L. M. Duffy, A. L. Chapman, P. J. Shaw, A. J. Grierson
Volume 37, Issue 4

Molecular genetics and pathology of hereditary small vessel diseases of the brain
Y. Yamamoto, L. Craggs, M. Baumann, H. Kalimo, R. N. Kalaria
Volume 37, Issue 1

Top Cited papers Cited in 2012
Source items published in 2010

The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity – a tale of conflict and conundrum
M. Müller, S. Carter, M. J. Hofer, I. L. Campbell
Volume 36, Issue 5

Autophagy and neurodegeneration: survival at a cost?
S. J. Cherra III, R. K. Dagda, C. T. Chu
Volume 36, Issue 2

Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3
M. Shioya, S. Obayashi, H. Tabunoki, K. Arima, Y. Saito, T. Ishida, J. Satoh
Volume 36, Issue 4

Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer-type pathology in the ageing brain
J. E. Simpson, P. G. Ince, L. J. Haynes, R. Theaker, C. Gelsthorpe, L. Baxter, G. Forster, G. L. Lace, P. J. Shaw, F. E. Matthews, G. M. Savva, C. Brayne, S. B. Wharton
Volume 36, Issue 1

Transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration
T. F. Gendron, K. A. Josephs, L. Petrucelli
Volume 36, Issue 2

Cell cycle aberrations and neurodegeneration
D. J. Bonda, V. P. Bajić, B. Spremo-Potparevic, G. Casadesus, X. Zhu,
M. A. Smith, H.-G. Lee
Volume 36, Issue 2

Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology
D-H. Lee, I. Metz, A. Berthele, C. Stadelmann, W. Brück, R. A. Linker,
R. Gold, A. Schroeder
Volume 36, Issue 7

Contribution of transgenic models to understanding human prion disease
J. D. F. Wadsworth, E. A. Asante, J. Collinge
Volume 36, Issue 7

Neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy
L. M. Murray, K. Talbot, T. H. Gillingwater
Volume 36, Issue 2

Expression of diagnostic neuronal markers and outcome in glioblastoma
K. Donev, B. W. Scheithauer, F. J. Rodriguez, S. Jenkins
Volume 36, Issue 5

  Copyright © John Wiley & Sons, Inc. or related companies. All rights reserved. Wiley Logo